Merck inks $200 million deal for Hengrui's midstage heart disease drug
Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region
Hengrui Pharma has granted Merck exclusive rights to develop, manufacture and commercialize HRS-5346 worldwide, excluding Greater China region
The two have agreed to jointly undertake R&D activities on scientific validation of Ayush concepts, procedures and products
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
The latest BioE3 policy builds the framework for high-performance biomanufacturing to propel the development and production
Plant-based chemistries have an outsized role to play for the HPC sector by meeting demand for good, gentle, and green products
Anti-cancer patent now validated in Spain, the UK, and as a Unitary Patent covering multiple EU member states
The Protect VL project was born out of a vision to reduce the environmental footprint of medical devices
The partnership provides Sai Life Sciences with a greenhouse gas emissions reduction of up to 90% for its international logistics needs by using SAF
Subscribe To Our Newsletter & Stay Updated